※March Drug Marketing Approval Hotspots Update | A dry suspension of amlodipine besylate failed to obtain approval for market launch, drawing industry attention to the quality and compliance of related active pharmaceutical ingredients (APIs) ☜

It is important to note that amlodipine besylate, as a clinically commonly used calcium channel blocker, is widely applied in the treatment of hypertension and coronary heart disease, with stable and urgent market demand 

✔ The marketing approval of its formulation fundamentally relies on high-quality APIs—the purity and stability of raw materials directly determine the efficacy and safety of the formulation, and constitute one of the key considerations in the approval process.

Against this backdrop, our company has launched the imported generic active pharmaceutical ingredient "Amlodipine Besylate", which has been approved for import, providing a core solution for pharmaceutical formulation enterprises to overcome regulatory approval challenges and strengthen product foundations!

✔ Compliance Assurance: The entire production process adheres to international GMP standards, with successful approval for importation. All parameters comply with national pharmaceutical standards, perfectly meeting the requirements for formulation development, production, and marketing authorization, thereby mitigating approval risks caused by non-compliant raw materials. 

✔ Quality Benchmarking: As an overseas generic drug raw material, it strictly replicates the original research material's manufacturing process, ensuring high purity of active ingredients, strong batch stability, and bioavailability comparable to imported original materials, eliminating concerns about batch variation affecting formulation efficacy. 

✔ Broad Compatibility: Suitable for the R&D and production of various dosage forms including tablets, dispersible tablets, and dry suspensions, covering indications such as hypertension, chronic stable angina pectoris, and angina pectoris due to vasospasm, catering to diverse patient populations, particularly for formulation development targeting elderly and pediatric patients with swallowing difficulties.

 ✔ Stable Supply Chain: Direct overseas procurement ensures source control of raw material quality, providing stable and efficient supply, which accelerates R&D progress for formulation enterprises, shortens market entry cycles, and secures competitive advantages in the market.

Optimal raw material selection for streamlined approval processes! ☞ If you are concerned about raw material issues for the R&D and marketing approval of amlodipine besylate preparations, consider our company's approved imported generic active pharmaceutical ingredient. Our professional team provides end-to-end support to facilitate product launch and market penetration.